2013 - IPITA 2013 Congress


This page contains exclusive content for the member of the following sections: TTS, IPITA. Log in to view.

Parallel Session 1 on Clinical Allogeneic Islet Transplantation

5.6 - Islet allotransplantation in type 1 diabetes: phase 2 pilot study with CXCL8 inhibitor (reparixin).

Presenter: Paola, Maffi, Roma, Italy
Authors:

Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada